SELLAS Life Sciences Group, Inc.

Bank of New York Mellon Corp SLS

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

256,409

Value ($000)

967

Weight

0.0%

2020 Q1 - 2025 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	967	0.0%	256,409	12/31/2025
2025 Q3	11/3/2025	331	0.0%	205,682	9/30/2025
2025 Q2	8/5/2025	441	0.0%	201,460	6/30/2025
2023 Q4	1/29/2024	90	0.0%	84,665	12/31/2023
2023 Q3	10/24/2023	33	0.0%	20,414	9/30/2023
2023 Q2	8/3/2023	33	0.0%	20,743	6/30/2023
2023 Q1	5/9/2023	30	0.0%	20,832	3/31/2023
2022 Q4	2/14/2023	49	0.0%	20,832	12/31/2022
2022 Q3	11/14/2022	41	0.0%	20,247	9/30/2022
2022 Q2	8/15/2022	45	0.0%	20,247	6/30/2022
2022 Q1	5/11/2022	140	0.0%	20,977	3/31/2022
2021 Q4	2/11/2022	116	0.0%	20,977	12/31/2021
2021 Q3	11/18/2021	192	0.0%	20,977	9/30/2021
2021 Q2	8/11/2021	226	0.0%	20,332	6/30/2021
2021 Q1	5/13/2021	133	0.0%	15,604	3/31/2021
2020 Q4	2/9/2021	94	0.0%	16,109	12/31/2020
2020 Q3	11/12/2020	43	0.0%	16,109	9/30/2020
2020 Q2	8/12/2020	47	0.0%	16,109	6/30/2020
2020 Q1	5/6/2020	28	0.0%	16,109	3/31/2020